MYH2 and metabolic dysfunction-associated steatotic liver disease: Conversely, systemic insulin resistance and inflammation induced by NAFLD may indirectly affect MYH2 expression and skeletal muscle function (42, 43).The role of MYH2 in muscle metabolism, inflammatory responses, and chronic diseases underscores its potential as a therapeutic target.